Lipidomic profiling before and after Roux-en-Y gastric bypass in obese patients with diabetes (original) (raw)
References
Cohen R, Caravatto PP, Petry T, Cummings D . Role of metabolic surgery in less obese or non-obese subjects with type 2 diabetes: influence over cardiovascular events. Curr Atheroscler Rep 2013; 15: 355. Google Scholar
Vidal J, Jimenez A . Diabetes remission following metabolic surgery: is glp-1 the culprit? Curr Atheroscler Rep 2013; 15: 357. Google Scholar
Huang H, Kasumov T, Gatmaitan P, Heneghan HM, Kashyap SR, Schauer PR et al. Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity (Silver Spring) 2011; 19: 2235–2240. Google Scholar
Simonen M, Dali-Youcef N, Kaminska D, Venesmaa S, Kakela P, Paakkonen M et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg 2012; 22: 1473–1480. Google Scholar
Heneghan HM, Huang H, Kashyap SR, Gornik HL, McCullough AJ, Schauer PR et al. Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio. Surg Obes Relat Dis 2013; 9: 100–107. Google Scholar
Stemmer K, Bielohuby M, Grayson BE, Begg DP, Chambers AP, Neff C et al. Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats. Endocrinology 2013; 154: 2015–2024. Google Scholar
Kosinska MK, Liebisch G, Lochnit G, Wilhelm J, Klein H, Kaesser U et al. A Lipidomic study of phospholipid classes and species in human synovial fluid. Arthritis Rheum 2013; 65: 2323–2333. Google Scholar
To VT, Huttl TP, Lang R, Piotrowski K, Parhofer KG . Changes in body weight, glucose homeostasis, lipid profiles, and metabolic syndrome after restrictive bariatric surgery. Exp Clin Endocrinol Diabetes 2012; 120: 547–552. Google Scholar
Graessler J, Schwudke D, Schwarz PE, Herzog R, Shevchenko A, Bornstein SR . Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS One 2009; 4: e6261. Google Scholar
Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D . Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 2008; 49: 1137–1146. Google Scholar
Schuhmann K, Almeida R, Baumert M, Herzog R, Bornstein SR, Shevchenko A . Shotgun lipidomics on a LTQ Orbitrap mass spectrometer by successive switching between acquisition polarity modes. J Mass Spectrom 2012; 47: 96–104. Google Scholar
Herzog R, Schwudke D, Schuhmann K, Sampaio JL, Bornstein SR, Schroeder M et al. A novel informatics concept for high-throughput shotgun lipidomics based on the molecular fragmentation query language. Genome Biol 2011; 12: R8. Google Scholar
Dirksen C, Jorgensen NB, Bojsen-Moller KN, Jacobsen SH, Hansen DL, Worm D et al. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia 2012; 55: 1890–1901. Google Scholar
Lima MM, Pareja JC, Alegre SM, Geloneze SR, Kahn SE, Astiarraga BD et al. Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 2010; 95: 3871–3875. Google Scholar
Despres JP . Cardiovascular disease under the influence of excess visceral fat. Crit Pathw Cardiol 2007; 6: 51–59. Google Scholar
Vix M, Diana M, Liu KH, D'Urso A, Mutter D, Wu HS et al. Evolution of glycolipid profile after sleeve gastrectomy vs. Roux-en-Y gastric bypass: results of a prospective randomized clinical trial. Obes Surg 2013; 23: 613–621. Google Scholar
Li Q, Chen L, Yang Z, Ye Z, Huang Y, He M et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index<35 kg/m2. Diabetes Obes Metab 2013; 14: 262–270. Google Scholar
Raffaelli M, Guidone C, Callari C, Iaconelli A, Bellantone R, Mingrone G . Effect of gastric bypass versus diet on cardiovascular risk factors. Ann Surg 2013: 1–6 doi:10.1097/SLA.0b013e31829d6989(e-pub ahead of print).
Pietilainen KH, Sysi-Aho M, Rissanen A, Seppanen-Laakso T, Yki-Jarvinen H, Kaprio J et al. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects - a monozygotic twin study. PLoS One 2007; 2: e218. Google Scholar
Zhao X, Fritsche J, Wang J, Chen J, Rittig K, Schmitt-Kopplin P et al. Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics 2010; 6: 362–374. Google Scholar
Huo T, Cai S, Lu X, Sha Y, Yu M, Li F . Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride. J Pharm Biomed Anal 2009; 49: 976–982. Google Scholar
Han MS, Lim YM, Quan W, Kim JR, Chung KW, Kang M et al. Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. J Lipid Res 2011; 52: 1234–1246. Google Scholar
Heilbronn LK, Coster AC, Campbell LV, Greenfield JR, Lange K, Christopher MJ et al. The effect of short-term overfeeding on serum lipids in healthy humans. Obesity (Silver Spring) 2013; 21: E649–E659. Google Scholar
Barber MN, Risis S, Yang C, Meikle PJ, Staples M, Febbraio MA et al. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS One 2012; 7: e41456. Google Scholar
Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007; 5: 167–179. Google Scholar
Meikle PJ, Wong G, Barlow CK, Weir JM, Greeve MA, Macintosh GL et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One 2013; 8: e74341. Google Scholar
Maris M, Robert S, Waelkens E, Derua R, Hernangomez MH, D'Hertog W et al. Role of the saturated nonesterified fatty acid palmitate in beta cell dysfunction. J Proteome Res 2013; 12: 347–362. Google Scholar
Mayneris-Perxachs J, Guerendiain M, Castellote AI, Estruch R, Covas MI, Fito M et al. Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease. PLoS One 2013; 8: e74341. Google Scholar
Mahendran Y, Cederberg H, Vangipurapu J, Kangas AJ, Soininen P, Kuusisto J et al. Glycerol and Fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in finnish men. Diabetes Care 2013; 36: 3732–3738. Google Scholar
Warensjo E, Riserus U, Vessby B . Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 2005; 48: 1999–2005. Google Scholar
Virtanen JK, Mursu J, Voutilainen S, Uusitupa M, Tuomainen TP . Serum omega-3 polyunsaturated fatty acids and risk of incident type 2 diabetes in men: the kuopio ischaemic heart disease risk factor study. Diabetes Care 2013 doi:10.2337/dc13-1504(e-pub ahead of print).
Bojsen-Moller KN, Dirksen C, Jorgensen NB, Jacobsen SH, Hansen DL, Worm D et al. Increased hepatic insulin clearance after Roux-en-Y gastric bypass. J Clin Endocrinol Metab 2013; 98: E1066–E1071. Google Scholar
Immonen H, Hannukainen JC, Iozzo P, Soinio M, Salminen P, Lepomaki V et al. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients. J Hepatol 2013 doi:10.1016/j.jhep.2013.09.012(e-pub ahead of print).
van der Veen JN, Lingrell S, Vance DE . The membrane lipid phosphatidylcholine is an unexpected source of triacylglycerol in the liver. J Biol Chem 2012; 287: 23418–23426. Google Scholar
Graessler J, Qin Y, Zhong H, Zhang J, Licinio J, Wong ML et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J 2013; 13: 514–522. Google Scholar
Vareka T, Vecka M, Jirak R, Tvrzicka E, Macasek J, Zak A et al. Plasma fatty acid profile in depressive disorder resembles insulin resistance state. Neuro Endocrinol Lett 2012; 33 (Suppl 2): 83–86. Google Scholar